Skip to main content
OpenTrials

Clinical trial condition

Stage II Bladder Urothelial Carcinoma AJCC v6 and v7

Explore clinical trials studying Stage II Bladder Urothelial Carcinoma AJCC v6 and v7. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 trial results

Recruiting

Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study

NCT05987241

Conditions
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma, Muscle Invasive Ureter Urothelial Carcinoma, +4 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
View all 500 locations
View Trial Details
Active, Not Recruiting

Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer

NCT03244384

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Localized Renal Pelvis and Ureter Urothelial Carcinoma, +19 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 915 locations
View Trial Details

Related conditions